These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 9222707

  • 1. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study.
    Miller K.
    Hepatogastroenterology; 1997; 44(15):872-9. PubMed ID: 9222707
    [Abstract] [Full Text] [Related]

  • 2. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM.
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 5. [Nonvariceal upper gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drugs in Metropolitan Lima].
    Salvatierra Laytén G, de la Cruz Romero L, Paulino Merino M, Vidal Vidal V, Rivera Dávila C, Cano Chuquilin A, Frisancho Velarde O.
    Rev Gastroenterol Peru; 2006 Oct; 26(1):13-20. PubMed ID: 16622483
    [Abstract] [Full Text] [Related]

  • 6. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M.
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [Abstract] [Full Text] [Related]

  • 7. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions.
    Pulanić R, Dubravcić D, Ostojić-Pulanić B, Vrhovac B.
    Acta Med Croatica; 1998 Oct; 52(2):91-8. PubMed ID: 9682495
    [Abstract] [Full Text] [Related]

  • 8. Sucralfate therapy in NSAID bleeding gastropathy.
    Malagelada JR, Rodríguez de la Serna A, Dammann HG, Pons M, Armas C, Sala M, Tena X, Celdrán E, Mesa A.
    Clin Gastroenterol Hepatol; 2003 Jan; 1(1):51-6. PubMed ID: 15017517
    [Abstract] [Full Text] [Related]

  • 9. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
    Wilcox CM, Shalek KA, Cotsonis G.
    Arch Intern Med; 1994 Jan 10; 154(1):42-6. PubMed ID: 8267488
    [Abstract] [Full Text] [Related]

  • 10. Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices.
    Yoshida H, Mamada Y, Taniai N, Mineta S, Kawano Y, Mizuguchi Y, Kakinuma D, Kanda T, Tajiri T.
    Hepatogastroenterology; 2009 Jan 10; 56(94-95):1366-70. PubMed ID: 19950793
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 10; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 12. NSAID-induced gastric mucosal damage.
    Semble EL, Wu WC.
    Am Fam Physician; 1987 Jun 10; 35(6):101-8. PubMed ID: 3332745
    [Abstract] [Full Text] [Related]

  • 13. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor.
    Goldstein JL, Silverstein FE, Agrawal NM, Hubbard RC, Kaiser J, Maurath CJ, Verburg KM, Geis GS.
    Am J Gastroenterol; 2000 Jul 10; 95(7):1681-90. PubMed ID: 10925968
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial.
    Simon LS, Hatoum HT, Bittman RM, Archambault WT, Polisson RP.
    Fam Med; 1996 Mar 10; 28(3):204-10. PubMed ID: 8900554
    [Abstract] [Full Text] [Related]

  • 15. Gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
    Festen HP.
    Neth J Med; 1989 Dec 10; 35(5-6):327-33. PubMed ID: 2699655
    [Abstract] [Full Text] [Related]

  • 16. Gastroduodenal complications of chronic NSAID therapy.
    Graham DY, Smith JL.
    Am J Gastroenterol; 1988 Oct 10; 83(10):1081-4. PubMed ID: 3048080
    [Abstract] [Full Text] [Related]

  • 17. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
    Lazzaroni M, Sainaghi M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Oct 10; 31 Suppl 1():S48-53. PubMed ID: 10379470
    [Abstract] [Full Text] [Related]

  • 18. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI.
    Ital J Gastroenterol Hepatol; 1999 Oct 10; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [Abstract] [Full Text] [Related]

  • 19. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov 10; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 20. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
    Rybár I, Masaryk P, Mateicka F, Kopecký S, Rovenský J.
    Int J Clin Pharmacol Res; 2001 Nov 10; 21(3-4):119-25. PubMed ID: 12067141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.